Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL* protocol

• Main Authors: Juan José Cerezo-Manchado (Author), Olga Meca Birlanga (Author), Luis García de Guadiana Romualdo (Author), Ignacio Gil-Ortega (Author), Antonio Martínez Francés (Author), Teodoro Iturbe-Hernandez (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

COVID-19 increases the risk of atrial fibrillation (AF) and thrombotic complications, particularly in severe cases, leading to higher mortality rates. Anticoagulation is the cornerstone to reduce thromboembolic risk in patients with AF. Considering the risk of hepatotoxicity in patients with severe...